Sorted By Test Name - Mayo Medical Laboratories

FAPP
91428
Reference Values:
or =18 years: 63-137 ng/mL
Clinical References: 1. Cavusoglu E, Ruwende C, Chopra V, et al: Relationship of baseline plasma
ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for
coronary angiography. Coron Artery Dis 2009;20:112-117 2. Cavusoglu E, Ruwende C, Chopra V, et al:
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men
with diabetes mellitus referred for coronary angiography. Atherosclerosis. 2010 May;210(1):226-231 3.
Krempl TK, Maas R, Sydow K, et al: Elevation of asymmetric dimethylarginine in patients with unstable
angina and recurrent cardiovascular events. Eur Heart J 2005;26:1846-1851 4. Valkonen VP, Paiva H,
Salonen JT, et al: Risk of acute coronary events and serum concentration of asymmetrical
dimethylarginine. Lancet 2001;358:2127-2128 5. Ravani P, Tripepi G, Malberti F, et al: Asymmetrical
dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a
competing risks modeling approach. J Am Soc Nephrol 2005;16:2449-2455 6. Abedini S, Meinitzer A,
Holme I, et al: Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and
all-cause mortality in renal transplant recipients. Kidney Int 2010 Jan;77(1):44-50 7. Maas R, Schulze F,
Baumert J, et al: Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently
healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in
Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and
experimental data. Clin Chem 2007 Apr;53(4):693-701
Atypical Pneumonia Antibody Panel
Reference Values:
Chlamydia and Chlamydophila Antibody Panel 3 (IgG, IgA, IgM)
C.Trachomatis, C.Pneumoniae, C.Psittaci (IgG, IgA, IgM )
Reference Range: IgG < 1:64
IgA < 1:16
IgM < 1:10
The immunofluorescent detection of specific antibodies to Chlamydia
trachomatis, Chlamydophila pneumoniae, and C. psittaci may be
complicated by crossreactive antibodies, non-specific antibody
stimulation, or past exposure to more than one of these organisms.
IgM titers of 1:10 or greater are indicative of recent infection; however,
IgM antibody is very crossreactive, often demonstrating titers to
multiple organisms. Any IgG titer may indicate past exposure to that
particular organism. Infection by a particular organism typically yields
IgG titers that are higher than antibody titers to non-infecting organisms.
IgA titers may help to identify the infecting organism when
crossreactive IgG is present. IgA is typically present at low titers
during primary infection, but may be elevated in recurrent exposures
or in chronic infection.
Legionella Pneumophila Antibodies (Total)
L. pneumophila (serogroup 1) and (serogroups 2-6, 8)
Reference Ranges:
L. pneumophila (serogroup 1)